Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schachter

Showing results (51-60 of 153) with videos related to

Pageof 16
Sort By:
Frontiers in Oncology|June 5, 2023
Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanomaRonen Stoff, Nethanel Asher, Shachar Laks, et al.
Neoplasia (New York, N.Y.)|March 21, 2018
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma CellsKarin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, et al.
Therapeutic Advances in Medical Oncology|November 7, 2022
Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patientsShirly Grynberg, Ronen Stoff, Nethanel Asher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating LymphocytesRonny Ben-Avi, Orit Itzhaki, David Simansky, et al.
Autoimmunity Reviews|January 18, 2018
Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitorsMerav Lidar, Eitan Giat, Daniela Garelick, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2018
Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanomaGuy Ben-Betzalel, Erez N Baruch, Ben Boursi, et al.
Open Biology|June 13, 2014
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complexEyal Greenberg, Steven Hajdu, Yael Nemlich, et al.
Bone Marrow Transplantation|February 28, 2019
Early and late hematologic toxicity following CD19 CAR-T cellsShalev Fried, Abraham Avigdor, Bella Bielorai, et al.
The Oncologist|February 20, 2019
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint InhibitorsNethanel Asher, Edith M Marom, Guy Ben-Betzalel, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2018
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patientsRonny Ben-Avi, Ronit Farhi, Alon Ben-Nun, et al.
Pageof 16

Showing results (51-60 of 153) with videos related to

Sort By:
Pageof 16
Frontiers in Oncology|June 5, 2023
Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanomaRonen Stoff, Nethanel Asher, Shachar Laks, et al.
Neoplasia (New York, N.Y.)|March 21, 2018
Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma CellsKarin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, et al.
Therapeutic Advances in Medical Oncology|November 7, 2022
Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patientsShirly Grynberg, Ronen Stoff, Nethanel Asher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating LymphocytesRonny Ben-Avi, Orit Itzhaki, David Simansky, et al.
Autoimmunity Reviews|January 18, 2018
Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitorsMerav Lidar, Eitan Giat, Daniela Garelick, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2018
Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanomaGuy Ben-Betzalel, Erez N Baruch, Ben Boursi, et al.
Open Biology|June 13, 2014
Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complexEyal Greenberg, Steven Hajdu, Yael Nemlich, et al.
Bone Marrow Transplantation|February 28, 2019
Early and late hematologic toxicity following CD19 CAR-T cellsShalev Fried, Abraham Avigdor, Bella Bielorai, et al.
The Oncologist|February 20, 2019
Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint InhibitorsNethanel Asher, Edith M Marom, Guy Ben-Betzalel, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2018
Establishment of adoptive cell therapy with tumor infiltrating lymphocytes for non-small cell lung cancer patientsRonny Ben-Avi, Ronit Farhi, Alon Ben-Nun, et al.
Pageof 16